CHF Solutions, Inc. Announces Board and Committee Changes
September 27, 2019 at 04:30 pm EDT
Share
On September 24, 2019, CHF Solutions, Inc. announced Matthew E. Likens tendered his resignation from the Board of Directors (the Board"), the Audit Committee of the Board and the Nominating and Corporate Governance Committee of the Board, effective as of September 24, 2019. Mr. Likens has decided to step down from the Board given the increased demands placed on him as the Chief Executive Officer of another company. In connection with Mr. Liken's departure, Warren S. Watson has been appointed by the Board to serve as one of the three members of the Audit Committee of the Board.
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.